NCT Research

NCT Trial Center News

Figure 1: Recruiting of patients is exceeding expectations.

What is INFORM?INFORM is a program for children with relapsed or progressive malignancies for which...

Image courtesy of Stuart Miles at FreeDigitalPhotos.net

The study „Targeting IDH1R132H in WHO grade III-IV IDH1R132H-mutated gliomas by a peptide vaccine –...

Topics of the NCT Trial Center´s newsletter in June 2017 are: REMOTUX, a phase II study with...

© Melinda Nagy | Dreamstime Stock Photos

Topics for the NCT Trial Center´s newsletter in November 2016 are the clinical trials: CTLA-4...

Image courtesy of Stuart Miles at FreeDigitalPhotos.net

The “phase II trial of Ipilimumab in patients with advanced melanoma and spontaneous preexisting...

Topics for the NCT Trial Center´s newsletter in May 2016 are • the clinical trial ATACC with an...

Figure 1: GMP manufacturing of the patient individual, activated T-cells is carried out by the team of Prof. Dr. Eichmüller at the DKFZ. ©DKFZ

In May 2016 the clinical trial ATACC started recruitment. It is a phase I trial of adoptive T cell...

Treffer 1 bis 7 von 16

1

2

3

>